Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
LYEL2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in LYELL IMMUNOPHARMA INC
Yes. Vanguard Portfolio Management holds 91,891 shares of LYEL (Lyell Immunopharma), worth $1.3M, as of its Q2 2026 13F filing. It increased the position from 23,015 shares in Q1 2026. Vanguard Portfolio Management has held LYEL in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$1.3M
Current Shares
91,891
Total Value Change
+$829,388
Total Shares Change
+68,876
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.